A recent investigation into illegal clinical trials in India has been criticized for overlooking the human cost of these unethical practices. The probe, which was conducted in Ahmedabad, failed to address the impact on the individuals who were subjected to these illegal trials. It is imperative to consider the welfare of the participants who may have suffered adverse effects or exploitation during these trials. The findings of the investigation raise concerns about the regulatory framework governing clinical trials in the country and the need for stricter enforcement to protect the rights and safety of participants. The lack of accountability and transparency in these trials is a serious issue that needs to be addressed to prevent further harm to vulnerable individuals. The exploitation of participants in illegal clinical trials is a violation of ethical standards and poses significant risks to public health. It is essential for authorities to take action against those responsible for conducting these trials and to ensure that proper safeguards are in place to prevent such incidents in the future. The investigation underscores the importance of upholding ethical standards in medical research and the need for greater oversight to protect the well-being of participants.